EXELIXIS, INC

Organization

SOUTH SAN FRANCISCO, CA, US

Ticker Symbols

NASDAQ:EXEL

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Business Address
1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
Mailing Address
1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
State Location
CA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Processes for preparing quinoline compounds and pharmaceutical comp...
- Patent number 12,128,039
- Issue date Oct 29, 2024
- Exelixis, Inc.
- Jo Ann Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ROR antibody constructs
- Patent number 12,084,496
- Issue date Sep 10, 2024
- Exelixis, Inc.
- Lucas Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Liquid dosage forms to treat cancer
- Patent number 12,016,854
- Issue date Jun 25, 2024
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms and salt forms of a kinase inhibitor
- Patent number 12,017,995
- Issue date Jun 25, 2024
- Exelixis, Inc.
- Frenel DeMorin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer
- Patent number 11,969,419
- Issue date Apr 30, 2024
- Exelixis, Inc.
- David Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]ph...
- Patent number 11,760,726
- Issue date Sep 19, 2023
- Exelixis, Inc.
- Dana T. Aftab
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic adenosine receptor antagonists
- Patent number 11,718,622
- Issue date Aug 8, 2023
- Exelixis Inc.
- Sunghoon Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of kinase-dependent disorders
- Patent number 11,708,367
- Issue date Jul 25, 2023
- Exelixis, Inc.
- Lynne Canne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of kinase-dependent disorders
- Patent number 11,673,897
- Issue date Jun 13, 2023
- Exelixis, Inc.
- Lynne Canne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer
- Patent number 11,612,597
- Issue date Mar 28, 2023
- Exelixis, Inc.
- David Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MEK inhibitors and methods of their use
- Patent number 11,597,699
- Issue date Mar 7, 2023
- Exelixis, Inc.
- Naing Aay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cabozantinib dosage form and use in the treatment of cancer
- Patent number 11,564,915
- Issue date Jan 31, 2023
- Exelixis, Inc.
- Aaron Weitzman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of kinase-dependent disorders
- Patent number 11,542,259
- Issue date Jan 3, 2023
- Exelixis, Inc.
- Lynne Canne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer and bone cancer pain
- Patent number 11,504,363
- Issue date Nov 22, 2022
- Exelixis, Inc.
- Gisela Schwab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Liquid dosage forms to treat cancer
- Patent number 11,504,362
- Issue date Nov 22, 2022
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using c-Met modulators
- Patent number 11,433,064
- Issue date Sep 6, 2022
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for making compounds for use in the treatment of cancer
- Patent number 11,414,396
- Issue date Aug 16, 2022
- Exelixis, Inc.
- Sriram Naganathan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for preparing quinoline compounds and pharmaceutical comp...
- Patent number 11,298,349
- Issue date Apr 12, 2022
- Exelixis, Inc.
- Jo Ann Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-...
- Patent number 11,279,675
- Issue date Mar 22, 2022
- Exelixis, Inc.
- Khalid Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodoph...
- Patent number 11,254,649
- Issue date Feb 22, 2022
- Exelixis, Inc.
- Adrian St. Clair Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combinations of cabozantinib and atezolizumab to treat cancer
- Patent number 11,198,731
- Issue date Dec 14, 2021
- Exelixis, Inc.
- Gisela Schwab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyqu...
- Patent number 11,141,413
- Issue date Oct 12, 2021
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C-met modulator pharmaceutical compositions
- Patent number 11,123,338
- Issue date Sep 21, 2021
- Exelixis, Inc.
- Jo Ann Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C-met modulators and methods of use
- Patent number 11,124,482
- Issue date Sep 21, 2021
- Exelixis, Inc.
- Lynne Canne Bannen
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Method of preparing fluorine-18 labeled Cabozantinib and its analogs
- Patent number 11,124,481
- Issue date Sep 21, 2021
- Exelixis, Inc.
- Wei Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer
- Patent number 11,116,759
- Issue date Sep 14, 2021
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...
- Patent number 11,098,015
- Issue date Aug 24, 2021
- Exelixis, Inc.
- Adrian St. Clair Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...
- Patent number 11,091,440
- Issue date Aug 17, 2021
- Exelixis, Inc.
- Adrian St. Clair Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...
- Patent number 11,091,439
- Issue date Aug 17, 2021
- Exelixis, Inc.
- Adrian St. Clair Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Drug combinations to treat multiple myeloma
- Patent number 11,065,240
- Issue date Jul 20, 2021
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...
- Publication number 20240350477
- Publication date Oct 24, 2024
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING CANCER AND BONE CANCER PAIN
- Publication number 20240316030
- Publication date Sep 26, 2024
- Exelixis, Inc.
- Gisela Schwab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Liquid Dosage Forms to Treat Cancer
- Publication number 20240307367
- Publication date Sep 19, 2024
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS AND SALT FORMS OF A KINASE INHIBITOR
- Publication number 20240300897
- Publication date Sep 12, 2024
- Exelixis, Inc.
- Frenel DeMorin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N...
- Publication number 20240287002
- Publication date Aug 29, 2024
- Exelixis, Inc.
- Dana T. Aftab
- G01 - MEASURING TESTING
Information Patent Application
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...
- Publication number 20240279181
- Publication date Aug 22, 2024
- Exelixis, Inc.
- Adrian St. Clair Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR PREPARING QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMP...
- Publication number 20240189298
- Publication date Jun 13, 2024
- Exelixis, Inc.
- Jo Ann Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDONE COMPOUNDS AND METHODS OF USE
- Publication number 20240158393
- Publication date May 16, 2024
- Exelixis, Inc.
- Lynne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of Treating Cancer
- Publication number 20240156803
- Publication date May 16, 2024
- Exelixis, Inc.
- David Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C-Met Modulator Pharmaceutical Compositions
- Publication number 20240156804
- Publication date May 16, 2024
- Exelixis, Inc.
- Jo Ann Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Triple Negative Breast Cancer Treatment Method
- Publication number 20240148714
- Publication date May 9, 2024
- Exelixis, Inc.
- Sara M. TOLANEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Kinase-Dependent Disorders
- Publication number 20240150371
- Publication date May 9, 2024
- Exelixis, Inc.
- Lynne Canne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Kinase-Dependent Disorders
- Publication number 20240043414
- Publication date Feb 8, 2024
- Exelixis, Inc.
- Lynne Canne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC BINDING AGENTS AND USES THEREOF
- Publication number 20240010751
- Publication date Jan 11, 2024
- Exelixis, Inc.
- Bryan GLASER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE SOLID FORMS OF SALTS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-...
- Publication number 20240010621
- Publication date Jan 11, 2024
- Exelixis, Inc.
- Khalid Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PH...
- Publication number 20230382867
- Publication date Nov 30, 2023
- Exelixis, Inc.
- Dana T. Aftab
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic Adenosine Receptor Antagonists
- Publication number 20230382917
- Publication date Nov 30, 2023
- Exelixis, Inc.
- Sunghoon Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Kinase-Dependent Disorders
- Publication number 20230374024
- Publication date Nov 23, 2023
- Exelixis, Inc.
- Lynne Canne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD47 BINDING AGENTS AND USES THEREOF
- Publication number 20230357391
- Publication date Nov 9, 2023
- Exelixis, Inc.
- Bryan GLASER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AMH-COMPETITIVE ANTAGONIST ANTIBODY
- Publication number 20230348607
- Publication date Nov 2, 2023
- Exelixis, Inc.
- Jean-François PROST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING CANCER
- Publication number 20230314440
- Publication date Oct 5, 2023
- Exelixis, Inc.
- Christopher Del Nagro
- G01 - MEASURING TESTING
Information Patent Application
COMBINATIONS FOR THE TREATMENT OF CANCER
- Publication number 20230301979
- Publication date Sep 28, 2023
- Exelixis, Inc.
- Gisela Schwab
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of Treating Cancer
- Publication number 20230301980
- Publication date Sep 28, 2023
- Exelixis, Inc.
- David Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Liquid Dosage Forms to Treat Cancer
- Publication number 20230301978
- Publication date Sep 28, 2023
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-L1 BINDING AGENTS AND USES THEREOF
- Publication number 20230303699
- Publication date Sep 28, 2023
- Exelixis, Inc.
- Bryan GLASER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes for the Preparation of a Kinase Inhibitor
- Publication number 20230192619
- Publication date Jun 22, 2023
- Exelixis, Inc.
- Frenel DeMorin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Using C-Met Modulators
- Publication number 20230181559
- Publication date Jun 15, 2023
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...
- Publication number 20230167063
- Publication date Jun 1, 2023
- Exelixis, Inc.
- Adrian St. Clair Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS OF USE
- Publication number 20230151003
- Publication date May 18, 2023
- Exelixis, Inc.
- Lynne Bannen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of Treating Cancer and Bone Cancer Pain
- Publication number 20230149384
- Publication date May 18, 2023
- Exelixis, Inc.
- Gisela Schwab
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
88709216 - PREVAIL OVER CANCER
- Serial number 88709216
- Registration number 6212692
- Filing date Nov 27, 2019
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88359265 - COMBINE AND CONQUER
- Serial number 88359265
- Filing date Mar 27, 2019
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87678033 - EASE
- Serial number 87678033
- Registration number 5984925
- Filing date Nov 9, 2017
- Exelixis, Inc.
- 35 - Advertising
Information Trademark
87678041 - ACCESS. ASSISTANCE. ALONG THE JOURNEY.
- Serial number 87678041
- Registration number 6273110
- Filing date Nov 9, 2017
- Exelixis, Inc.
- 35 - Advertising
Information Trademark
87525424 - X
- Serial number 87525424
- Registration number 6420112
- Filing date Jul 12, 2017
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87525418 - X
- Serial number 87525418
- Registration number 6206020
- Filing date Jul 12, 2017
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87525396 - EXELIXIS
- Serial number 87525396
- Registration number 6211449
- Filing date Jul 12, 2017
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87525385 - RESILIENT TOGETHER
- Serial number 87525385
- Registration number 5822351
- Filing date Jul 12, 2017
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87525392 - RESILIENCE.RESULTS.REMISSION
- Serial number 87525392
- Filing date Jul 12, 2017
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87525413 - EXELIXIS
- Serial number 87525413
- Registration number 6211450
- Filing date Jul 12, 2017
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86932647 - EASE EXELIXIS ACCESS SERVICES
- Serial number 86932647
- Registration number 5242397
- Filing date Mar 8, 2016
- Exelixis, Inc.
- 35 - Advertising
Information Trademark
86927889 - CABOMETYX
- Serial number 86927889
- Registration number 6239881
- Filing date Mar 3, 2016
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86927896
- Serial number 86927896
- Registration number 6239882
- Filing date Mar 3, 2016
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86810858 - APTIMETYX
- Serial number 86810858
- Filing date Nov 5, 2015
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86810853 - EVMETYX
- Serial number 86810853
- Filing date Nov 5, 2015
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86810863 - APTAMETYX
- Serial number 86810863
- Filing date Nov 5, 2015
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86810843 - STAMETYX
- Serial number 86810843
- Filing date Nov 5, 2015
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86621339 - CABOMETYX
- Serial number 86621339
- Registration number 5105828
- Filing date May 6, 2015
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86471554 - CABOMETYX
- Serial number 86471554
- Filing date Dec 4, 2014
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85809480
- Serial number 85809480
- Registration number 4597975
- Filing date Dec 21, 2012
- Exelixis, Inc.
- 35 - Advertising
Information Trademark
85336883 - KOMETRIQ
- Serial number 85336883
- Filing date Jun 2, 2011
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85336889 - KOMETRIX
- Serial number 85336889
- Filing date Jun 2, 2011
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85336878 - KOMETRIQ
- Serial number 85336878
- Filing date Jun 2, 2011
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85336891 - KOMETRIX
- Serial number 85336891
- Filing date Jun 2, 2011
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85336897 - KOMETRIK
- Serial number 85336897
- Filing date Jun 2, 2011
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85336898 - KOMETRIK
- Serial number 85336898
- Filing date Jun 2, 2011
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85331878 - COMETRIQ
- Serial number 85331878
- Filing date May 26, 2011
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85331897 - COMETZANT
- Serial number 85331897
- Filing date May 26, 2011
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85331902 - CABMETYX
- Serial number 85331902
- Filing date May 26, 2011
- Exelixis, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85331903 - CABMETYX
- Serial number 85331903
- Filing date May 26, 2011
- Exelixis, Inc.
- 42 - Scientific and technological services and research and design relating thereto

EXELIXIS, INC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Processes for preparing quinoline compounds and pharmaceutical comp...

Anti-ROR antibody constructs

Liquid dosage forms to treat cancer

Crystalline forms and salt forms of a kinase inhibitor

Method of treating cancer

Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]ph...

Heterocyclic adenosine receptor antagonists

Compounds for the treatment of kinase-dependent disorders

Compounds for the treatment of kinase-dependent disorders

Method of treating cancer

MEK inhibitors and methods of their use

Cabozantinib dosage form and use in the treatment of cancer

Compounds for the treatment of kinase-dependent disorders

Method of treating cancer and bone cancer pain

Liquid dosage forms to treat cancer

Methods of using c-Met modulators

Process for making compounds for use in the treatment of cancer

Processes for preparing quinoline compounds and pharmaceutical comp...

Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-...

Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodoph...

Combinations of cabozantinib and atezolizumab to treat cancer

Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyqu...

C-met modulator pharmaceutical compositions

C-met modulators and methods of use

Method of preparing fluorine-18 labeled Cabozantinib and its analogs

Method of treating cancer

Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...

Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...

Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...

Drug combinations to treat multiple myeloma

Patents Applicationslast 30 patents

Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...

METHOD OF TREATING CANCER AND BONE CANCER PAIN

Liquid Dosage Forms to Treat Cancer

CRYSTALLINE FORMS AND SALT FORMS OF A KINASE INHIBITOR

METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N...

Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...

PROCESSES FOR PREPARING QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMP...

PYRIDONE COMPOUNDS AND METHODS OF USE

Method of Treating Cancer

C-Met Modulator Pharmaceutical Compositions

Triple Negative Breast Cancer Treatment Method

Compounds for the Treatment of Kinase-Dependent Disorders

Compounds for the Treatment of Kinase-Dependent Disorders

MULTISPECIFIC BINDING AGENTS AND USES THEREOF

CRYSTALLINE SOLID FORMS OF SALTS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-...

CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PH...

Heterocyclic Adenosine Receptor Antagonists

Compounds for the Treatment of Kinase-Dependent Disorders

CD47 BINDING AGENTS AND USES THEREOF

AMH-COMPETITIVE ANTAGONIST ANTIBODY

METHOD OF TREATING CANCER

COMBINATIONS FOR THE TREATMENT OF CANCER

Method of Treating Cancer

Liquid Dosage Forms to Treat Cancer

PD-L1 BINDING AGENTS AND USES THEREOF

Processes for the Preparation of a Kinase Inhibitor

Methods of Using C-Met Modulators

Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-...

COMPOUNDS AND METHODS OF USE

Method of Treating Cancer and Bone Cancer Pain

Trademarklast 30 trademarks

88709216 - PREVAIL OVER CANCER

88359265 - COMBINE AND CONQUER

87678033 - EASE

87678041 - ACCESS. ASSISTANCE. ALONG THE JOURNEY.

87525424 - X

87525418 - X

87525396 - EXELIXIS

87525385 - RESILIENT TOGETHER

87525392 - RESILIENCE.RESULTS.REMISSION

87525413 - EXELIXIS